David Olagnier_Dep of Biomedicine_Aarhus University (IMAGE)

Aarhus University

David Olagnier_Dep of Biomedicine_Aarhus University

Caption

Associate Professor David Olagnier from the Department of Biomedicine at Aarhus University is one of the lead researchers of a new study, that shows that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.

Credit

Simon Fischel. Aarhus University

Usage Restrictions

Only to be used in context of this press release

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.